Beiersdorf/€BEI
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Beiersdorf
Beiersdorf AG, with the stock ticker BEI, is a leading global company specializing in the development, manufacture, and marketing of personal care products and pressure-sensitive adhesives. Founded in 1882 and based in Hamburg, Germany, the company operates through key business segments including Consumer Business and tesa Business, offering renowned brands such as NIVEA, Eucerin, and Hansaplast. The company's extensive product line caters to both consumer and industrial applications, reinforcing Beiersdorf's stronghold in the skincare and adhesive markets.
- Ticker
- €BEI
- Sector
- Consumer Essentials
- Primary listing
- XETRA
- Employees
- 22,326
- Headquarters
- Hamburg, Germany
- Website
- www.beiersdorf.com
Beiersdorf Metrics
BasicAdvanced
€18B
18.90
€4.29
0.49
€1.00
1.23%
Price and volume
Market cap
€18B
Beta
0.49
52-week high
€108.45
52-week low
€67.06
Average daily volume
331K
Dividend rate
€1.00
Financial strength
Current ratio
1.998
Quick ratio
1.501
Long term debt to equity
0.012
Total debt to equity
0.012
Dividend payout ratio (TTM)
23.35%
Interest coverage (TTM)
56.91%
Profitability
EBITDA (TTM)
1,580
Gross margin (TTM)
57.13%
Net profit margin (TTM)
9.75%
Operating margin (TTM)
13.61%
Effective tax rate (TTM)
27.82%
Revenue per employee (TTM)
€430,000
Management effectiveness
Return on assets (TTM)
6.24%
Return on equity (TTM)
10.89%
Valuation
Price to earnings (TTM)
18.901
Price to revenue (TTM)
1.844
Price to book
1.96
Price to tangible book (TTM)
2.16
Price to free cash flow (TTM)
29.948
Free cash flow yield (TTM)
3.34%
Free cash flow per share (TTM)
2.707
Dividend yield (TTM)
1.23%
Forward dividend yield
1.23%
Growth
Revenue change (TTM)
-2.50%
Earnings per share change (TTM)
8.55%
3-year revenue growth (CAGR)
1.27%
10-year revenue growth (CAGR)
3.77%
3-year earnings per share growth (CAGR)
4.97%
10-year earnings per share growth (CAGR)
3.68%
3-year dividend per share growth (CAGR)
12.62%
10-year dividend per share growth (CAGR)
3.63%
What the Analysts think about Beiersdorf
Analyst ratings (Buy, Hold, Sell) for Beiersdorf stock.
Analyst projections of the future price of Beiersdorf stock.
Bulls say / Bears say
Derma is a clear growth engine: organic sales rose 7.8% in the first half, led by Eucerin and Aquaphor. Further expansion of Aquaphor into body lotions and creams could widen the opportunity. (Beiersdorf)
The tesa business showed resilience by returning to 2.5% organic growth in the second quarter after a weak first quarter. Its broader industrial portfolio held up, giving Beiersdorf a steadier second earnings stream while Consumer recovers. (Beiersdorf)
The shares have already been heavily de-rated, with UBS noting valuation around 17 times 2026 earnings and 7 times EV/EBITDA, below the European food and home-and-personal-care sector. If NIVEA stabilises, that lower starting valuation could leave room for recovery. (Investing.com)
NIVEA remains the central problem: its organic sales fell 6.7% in the second quarter, prompting Beiersdorf to cut 2026 group sales guidance from flat-to-slight growth to a low-single-digit decline. The company now expects its group EBIT margin to be at least 11.8%, versus 14.0% in 2025. (Reuters, Beiersdorf)
The NIVEA turnaround is costly before it is proven: Beiersdorf plans an additional €100 million of media spending in the second half while facing higher input costs. Management expects Consumer EBIT margin to fall to at least 11.0% in 2026 from 13.6% in 2025. (Beiersdorf, Reuters)
The recovery timetable may be too optimistic. Barclays said NIVEA’s problems appear longer-running and harder to fix than the market has priced in, while Beiersdorf’s valuation remains demanding despite limited evidence of a sales-volume upturn. (MarketScreener)
Data summarised monthly by Lightyear AI. Last updated on 24 Sept 2026.
Beiersdorf Financial Performance
Revenues and expenses
Beiersdorf Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Beiersdorf
AllEURGBPUSD
Fund name | Fund size | €BEI weighting |
|---|---|---|
iShares STOXX Europe 600 Personal & Household Goods€EXH7 | €184M | 0.92% |
iShares EURO STOXX Mid€DJMC | €572M | 0.88% |
iShares EURO STOXX Mid Cap£DJMC | £491M | 0.88% |
Amundi DAX III€DAX | €658M | 0.50% |
Amundi DAX II£DAXX | £572M | 0.43% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.